Other Species / Isoforms
  PI4K2A (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MDETsPLVsPER
Upstream
1 12
Treatment
  • nocodazole
PI4K2A (human) ___MDETsPLVsPER S5-p
PI4K2A (mouse) ___MDETsPLVsPER S5-p
PI4K2A (rat) ___MDETsPLVsPER S5-p
S9-p
DETsPLVsPERAQPP
Upstream
1 15
Treatment
  • nocodazole
PI4K2A (human) DETsPLVsPERAQPP S9-p
PI4K2A (mouse) DETsPLVsPERAQPP S9-p
PI4K2A (rat) DETsPLVsPERAQPP S9-p
Y18-p
ERAQPPDytFPSGSG
0 4
PI4K2A (human) ERAQPPDytFPSGSG Y18-p
PI4K2A (mouse) ERAQPPEYTFPSGSG Y18
PI4K2A (rat) ERAQPPEYTFPSVSG Y18
T19-p
RAQPPDytFPSGSGA
0 3
PI4K2A (human) RAQPPDytFPSGSGA T19-p
PI4K2A (mouse) RAQPPEYTFPSGSGA T19
PI4K2A (rat) RAQPPEYTFPSVSGA T19
S44-p
RVAAAAGsGPsPPGs
Upstream
0 11
Treatment
  • metastatic potential
PI4K2A (human) RVAAAAGsGPsPPGs S44-p
PI4K2A (mouse) RVAAAAGsGPsPPCs S44-p
PI4K2A (rat) VRVAAAGSGPsPPCs S43
S47-p
AAAGsGPsPPGsPGH
Upstream
1 76
Regulatory protein:
  • PRP4 (human)
Treatment
  • EGF
  • metastatic potential
  • nocodazole
PI4K2A (human) AAAGsGPsPPGsPGH S47-p
PI4K2A (mouse) AAAGsGPsPPCsPGH S47-p
PI4K2A (rat) AAAGSGPsPPCsPGH S46-p
S51-p
sGPsPPGsPGHDRER
Upstream
1 71
Regulatory protein:
  • PRP4 (human)
  • TBK1 (human)
Treatment
  • metastatic potential
PI4K2A (human) sGPsPPGsPGHDRER S51-p
PI4K2A (mouse) sGPsPPCsPGHDRER S51-p
PI4K2A (rat) SGPsPPCsPGHDRER S50-p
Y138-p
YQGSSGSyFVkDPQG
0 1
PI4K2A (human) YQGSSGSyFVkDPQG Y138-p
PI4K2A (mouse) YQGSSGSYFVkDSQG Y138
PI4K2A (rat) YQGSSGSYFVKDSQG Y137
K141-ub
SSGSyFVkDPQGRII
0 8
PI4K2A (human) SSGSyFVkDPQGRII K141-ub
PI4K2A (mouse) SSGSYFVkDSQGRIV K141-ub
PI4K2A (rat) SSGSYFVKDSQGRII K140
K152-ub
GRIIAVFkPKNEEPY
0 1
PI4K2A (human) GRIIAVFkPKNEEPY K152-ub
PI4K2A (mouse) GRIVAVFKPKNEEPY K152
PI4K2A (rat) GRIIAVFKPKNEEPY K151
K165-ub
PYGHLNPkWTKWLQK
0 2
PI4K2A (human) PYGHLNPkWTKWLQK K165-ub
PI4K2A (mouse) PYGHLNPKWTKWLQK K165
PI4K2A (rat) PYGNLNPKWTKWLQK K164
K240-m1
GKRLALEkVPkVGQR
0 1
PI4K2A (human) GKRLALEkVPkVGQR K240-m1
PI4K2A (mouse) GKRLALEKVPKVGQR K240
PI4K2A (rat) GKRLALEKVPKVGQR K239
K240-ub
GKRLALEkVPkVGQR
0 8
PI4K2A (human) GKRLALEkVPkVGQR K240-ub
PI4K2A (mouse) GKRLALEkVPKVGQR K240-ub
PI4K2A (rat) GKRLALEKVPKVGQR K239
K243-m1
LALEkVPkVGQRFNR
0 1
PI4K2A (human) LALEkVPkVGQRFNR K243-m1
PI4K2A (mouse) LALEkVPKVGQRFNR K243
PI4K2A (rat) LALEKVPKVGQRFNR K242
K243-ub
LALEkVPkVGQRFNR
0 2
PI4K2A (human) LALEkVPkVGQRFNR K243-ub
PI4K2A (mouse) LALEkVPKVGQRFNR K243
PI4K2A (rat) LALEKVPKVGQRFNR K242
K268-ub
QLFVEGYkDADYWLR
0 12
PI4K2A (human) QLFVEGYkDADYWLR K268-ub
PI4K2A (mouse) QLFVEGYkDADyWLR K268-ub
PI4K2A (rat) QLFVEGYKDADYWLR K267
Y272
EGYkDADYWLRRFEA
0 2
PI4K2A (human) EGYkDADYWLRRFEA Y272
PI4K2A (mouse) EGYkDADyWLRRFEA Y272-p
PI4K2A (rat) EGYKDADYWLRRFEA Y271
Y302-p
ERLVVLDyIIRNTDR
0 1
PI4K2A (human) ERLVVLDyIIRNTDR Y302-p
PI4K2A (mouse) ERLVVLDYIIRNTDR Y302
PI4K2A (rat) ERLVVLDYIIRNTDR Y301
K336-ub
DTDWVVVkEPVIkVA
Upstream
0 13
Treatment
  • vorinostat
PI4K2A (human) DTDWVVVkEPVIkVA K336-ub
PI4K2A (mouse) DTDWVMVREPVIkVA R336
PI4K2A (rat) DTDWVMVREPVIKVA R335
K341-ub
VVkEPVIkVAAIDNG
0 10
PI4K2A (human) VVkEPVIkVAAIDNG K341-ub
PI4K2A (mouse) MVREPVIkVAAIDNG K341-ub
PI4K2A (rat) MVREPVIKVAAIDNG K340
K354-ub
NGLAFPLkHPDSWRA
0 4
PI4K2A (human) NGLAFPLkHPDSWRA K354-ub
PI4K2A (mouse) NGLAFPLkHPDSWRA K354-ub
PI4K2A (rat) NGLAFPLKHPDSWRA K353
K373-ub
WAWLPQAkVPFSQEI
0 1
PI4K2A (human) WAWLPQAkVPFSQEI K373-ub
PI4K2A (mouse) WAWLPQAKVPFSQEI K373
PI4K2A (rat) WAWLPQAKVPFSQEI K372
K387-ub
IKDLILPkISDPNFV
0 1
PI4K2A (human) IKDLILPkISDPNFV K387-ub
PI4K2A (mouse) IKDLILPKISDPNFI K387
PI4K2A (rat) IKDLILPKISDPNFV K386
K406-ub
EDLYELFkkDPGFDR
0 1
PI4K2A (human) EDLYELFkkDPGFDR K406-ub
PI4K2A (mouse) EDLYELFKRDPGFDR K406
PI4K2A (rat) EDLYELFKKDPGFDR K405
K407-ub
DLYELFkkDPGFDRG
0 1
PI4K2A (human) DLYELFkkDPGFDRG K407-ub
PI4K2A (mouse) DLYELFKRDPGFDRG R407
PI4K2A (rat) DLYELFKKDPGFDRG K406
K418-ub
FDRGQFHkQIAVMRG
0 1
PI4K2A (human) FDRGQFHkQIAVMRG K418-ub
PI4K2A (mouse) FDRGQFHKQIAVMRG K418
PI4K2A (rat) FDRGQFHKQIAVMRG K417
T431-p
RGQILNLtQALkDNK
0 2
PI4K2A (human) RGQILNLtQALkDNK T431-p
PI4K2A (mouse) RGQILNLTQALkDNK T431
PI4K2A (rat) RGQILNLTQALKDNK T430
K435-ub
LNLtQALkDNKSPLH
0 2
PI4K2A (human) LNLtQALkDNKSPLH K435-ub
PI4K2A (mouse) LNLTQALkDNKSPLH K435-ub
PI4K2A (rat) LNLTQALKDNKSPLH K434
S460-p
TARSHQRsssEsytQ
0 9
PI4K2A (human) TARSHQRsssEsytQ S460-p
PI4K2A (mouse) TARSHQRsAsEsytQ S460-p
PI4K2A (rat) TARSHQRsSsESYTQ S459-p
S461-p
ARSHQRsssEsytQs
0 11
PI4K2A (human) ARSHQRsssEsytQs S461-p
PI4K2A (mouse) ARSHQRsAsEsytQs A461
PI4K2A (rat) ARSHQRsSsESYTQs S460
S462-p
RSHQRsssEsytQsF
Upstream
0 55
Regulatory protein:
  • PRP4 (human)
Treatment
  • ischemia
PI4K2A (human) RSHQRsssEsytQsF S462-p
PI4K2A (mouse) RSHQRsAsEsytQsF S462-p
PI4K2A (rat) RSHQRsSsESYTQsF S461-p
S464-p
HQRsssEsytQsFQS
0 9
PI4K2A (human) HQRsssEsytQsFQS S464-p
PI4K2A (mouse) HQRsAsEsytQsFQS S464-p
PI4K2A (rat) HQRsSsESYTQsFQS S463
Y465-p
QRsssEsytQsFQSR
0 36
PI4K2A (human) QRsssEsytQsFQSR Y465-p
PI4K2A (mouse) QRsAsEsytQsFQSR Y465-p
PI4K2A (rat) QRsSsESYTQsFQSR Y464
T466-p
RsssEsytQsFQSRk
0 4
PI4K2A (human) RsssEsytQsFQSRk T466-p
PI4K2A (mouse) RsAsEsytQsFQSRk T466-p
PI4K2A (rat) RsSsESYTQsFQSRK T465
S468-p
ssEsytQsFQSRkPF
Upstream
0 10
Treatment
  • CXCL12
PI4K2A (human) ssEsytQsFQSRkPF S468-p
PI4K2A (mouse) AsEsytQsFQSRkPF S468-p
PI4K2A (rat) SsESYTQsFQSRKPF S467-p
K473-ub
tQsFQSRkPFFSWW_
0 17
PI4K2A (human) tQsFQSRkPFFSWW_ K473-ub
PI4K2A (mouse) tQsFQSRkPFFSWW_ K473-ub
PI4K2A (rat) TQsFQSRKPFFSWW_ K472